| P50 | author | Sibnarayan Datta | Q42870711 |
| P2093 | author name string | Lokendra Singh | |
| | Rudragoud S Policegoudra | |
| | Soumya Chatterjee | |
| | Hemant K Gogoi | |
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| | Global cancer statistics | Q22241238 |
| | Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 |
| | The enigmatic X gene of hepatitis B virus | Q24561887 |
| | MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways | Q24650451 |
| | MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase | Q24653222 |
| | Viruses associated with human cancer | Q24653900 |
| | Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155 | Q24681400 |
| | Hepatitis G virus: is it a hepatitis virus? | Q27472732 |
| | Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses | Q27480882 |
| | Occult persistence and lymphotropism of hepatitis C virus infection | Q27488897 |
| | Genetic Characterization of Hepatitis B Virus in Peripheral Blood Leukocytes: Evidence for Selection and Compartmentalization of Viral Variants with the Immune Escape G145R Mutation | Q27489690 |
| | Interferon modulation of cellular microRNAs as an antiviral mechanism | Q27489711 |
| | The role of RNAi and microRNAs in animal virus replication and antiviral immunity | Q27490179 |
| | Six RNA Viruses and Forty-One Hosts: Viral Small RNAs and Modulation of Small RNA Repertoires in Vertebrate and Invertebrate Systems | Q27490914 |
| | A microRNA polycistron as a potential human oncogene | Q27860720 |
| | Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 |
| | MicroRNA signatures in human cancers | Q27860962 |
| | Hepatitis C virus infection | Q27861002 |
| | Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 |
| | The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 | Q28142473 |
| | Pesticides and non-Hodgkin's lymphoma | Q28189832 |
| | High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma | Q28236173 |
| | A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group | Q28246957 |
| | Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma | Q28260227 |
| | Regulation of the germinal center response by microRNA-155 | Q29547777 |
| | Hepatitis B virus infection--natural history and clinical consequences | Q29617961 |
| | MicroRNA control in the immune system: basic principles | Q29618112 |
| | Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs | Q29618428 |
| | Identification of microRNAs of the herpesvirus family | Q29618671 |
| | Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice | Q29619279 |
| | BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas | Q29622911 |
| | NS5ATP9, a gene up-regulated by HCV NS5A protein | Q33309415 |
| | GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study | Q42992649 |
| | No association between hepatitis C and B-cell lymphoma | Q42992786 |
| | Analysis of hepatitis G virus/GB virus C quasispecies and replication sites in human subjects | Q42993528 |
| | GB virus C infection and non-Hodgkin lymphoma: important to know but the jury is out. | Q42995433 |
| | Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus | Q42998036 |
| | Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. | Q42998904 |
| | Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process | Q42999023 |
| | Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. | Q43000908 |
| | Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma | Q43029933 |
| | Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins | Q43030664 |
| | Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies | Q43033839 |
| | High prevalence of hepatitis G virus infection in Hodgkin's disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection | Q43038609 |
| | Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection | Q43038794 |
| | Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia | Q43041636 |
| | Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study | Q44010172 |
| | The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis | Q44254387 |
| | Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation | Q44399985 |
| | High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea | Q45395665 |
| | High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma | Q45396618 |
| | Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection | Q45403597 |
| | High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers | Q45406721 |
| | High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma | Q45418194 |
| | Frequent joining of Bcl-2 to a JH6 gene in hepatitis C virus-associated t(14;18). | Q45598018 |
| | Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study | Q45723848 |
| | Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas | Q45730654 |
| | Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice | Q45733379 |
| | Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France | Q45737062 |
| | The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection | Q45738333 |
| | bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection | Q45738841 |
| | T(14;18) translocation in chronic hepatitis C virus infection | Q45744785 |
| | The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. | Q45767731 |
| | Cancer as a complex developmental disorder--nineteenth Cornelius P. Rhoads Memorial Award Lecture | Q48379952 |
| | Causation and causal inference in epidemiology. | Q52043839 |
| | Viruses in human cancers | Q56486194 |
| | Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia | Q57234164 |
| | Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy | Q58282405 |
| | Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II | Q73053045 |
| | Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases | Q74097228 |
| | HBV-encoded microRNA candidate and its target | Q79916260 |
| | Management of non-Hodgkin's lymphomas | Q33682014 |
| | EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3 | Q33793531 |
| | Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model | Q33916593 |
| | BCL-6 in the pathogenesis of non-Hodgkin's lymphoma | Q33917162 |
| | Molecular diagnostic approach to non-Hodgkin's lymphoma | Q33936373 |
| | Hepatitis C virus-related lymphoproliferative disorders: an overview. | Q34098553 |
| | Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1 | Q34142942 |
| | Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? | Q34296276 |
| | The multistep nature of cancer | Q34366937 |
| | Pesticides and cancer | Q34459951 |
| | Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting | Q34549509 |
| | Prevalence of hepatitis C virus and hepatitis G virus in patients with non-Hodgkin's lymphoma | Q34621540 |
| | Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways | Q34721581 |
| | Hepatitis C virus, B-cell proliferation and lymphomas. | Q34769865 |
| | Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies | Q34785970 |
| | Viral and cellular microRNAs as determinants of viral pathogenesis and immunity | Q34815231 |
| | Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence | Q34883074 |
| | miR-155 gene: a typical multifunctional microRNA. | Q34958384 |
| | Advances in the treatment of non-Hodgkin's lymphoma | Q34981057 |
| | Update on epidemiology and therapeutics for non-Hodgkin's lymphoma | Q35006646 |
| | Novel therapeutics for aggressive non-Hodgkin's lymphoma | Q35111768 |
| | Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication | Q35139319 |
| | Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells | Q35203879 |
| | Immunosuppressive therapy and acquired immunological disorders | Q35368828 |
| | Increasing incidence of non-Hodgkin's lymphoma: occupational and environmental factors. | Q35368958 |
| | Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. | Q35629704 |
| | Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma | Q35764338 |
| | B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review | Q35797604 |
| | The epidemiology of non-Hodgkin's lymphoma | Q35868057 |
| | Individuals with HGV-RNA are at high risk of B cell non-Hodgkin's lymphoma development. | Q36229917 |
| | Staging non-Hodgkin lymphoma | Q36311119 |
| | Analysis of the interaction of primate retroviruses with the human RNA interference machinery | Q36315550 |
| | Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis | Q36692164 |
| | Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. | Q36748177 |
| | Infectious agents as causes of non-Hodgkin lymphoma | Q36751505 |
| | Viruses, microRNAs, and host interactions | Q36753937 |
| | The non-Hodgkin lymphomas: a review of the epidemiologic literature | Q36778875 |
| | Hepatitis C virus lymphotropism: lessons from a decade of studies. | Q36971058 |
| | miRNA: the new gene silencer. | Q36976996 |
| | Hematopoietic malignancies associated with viral and alcoholic hepatitis | Q37003041 |
| | Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6 | Q37142068 |
| | microRNAs and the immune response | Q37178538 |
| | Overview of lymphoma diagnosis and management. | Q37213296 |
| | MicroRNAs: new regulators of immune cell development and function | Q37223449 |
| | NS5A--from obscurity to new target for HCV therapy | Q37232676 |
| | Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes | Q37356991 |
| | Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis | Q37610513 |
| | Physiological and pathological roles for microRNAs in the immune system | Q37680666 |
| | Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. | Q37801513 |
| | Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma | Q39890346 |
| | Downregulation of microRNAs-143 and -145 in B-cell malignancies | Q40076849 |
| | Non-Hodgkin's lymphomas: current classification and management | Q41643931 |
| | Hepatitis B virus infection associated with hematopoietic tumors. | Q42049928 |
| | Micro-RNA Expression and Function in Lymphomas | Q42703031 |
| | Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. | Q42977076 |
| | Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy | Q42977101 |
| | GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D. | Q42984090 |
| | Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells | Q42984420 |
| | Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. | Q42987134 |
| | HCV and HGV in B-cell non-Hodgkin's lymphoma | Q42987337 |
| | Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells | Q42987718 |
| | Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice | Q42988931 |
| | The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study | Q42989114 |
| | Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience | Q42990067 |
| P433 | issue | 6 | |
| P304 | page(s) | 162-173 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | World journal of virology | Q27725044 |
| P1476 | title | Hepatitis viruses and non-Hodgkin's lymphoma: A review | |
| P478 | volume | 1 | |